...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Phase 3 BETonMACE Trial is Now Completed. Cognition and CKD Sub-Study Results to be Announced Soon.

Message: Re: Resverlogix to Present at the European Society of Cardiology’s ESC Congress 2019

Bear that puts topline 21 calendar days from today. (3 weeks away)



New Message
Please login to post a reply